Panax quinquefolius whole
- Generic Name
- Panax quinquefolius whole
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 8W75VCV53Q
- Background
Panax quinquefolius whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Associated Conditions
- -
- Associated Therapies
- -
Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
Early Phase 1
Completed
- Conditions
- Stage I Colon Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7Stage III Colon Cancer AJCC v7Stage II Breast Cancer AJCC v6 and v7Stage IIIB Breast Cancer AJCC v7Cancer SurvivorStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7Stage IIA Colon Cancer AJCC v7
- Interventions
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2023-01-05
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 2
- Registration Number
- NCT03407716
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2018-07-10
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 96
- Registration Number
- NCT01500096
- Locations
- 🇺🇸
The Johns Hopkins University, Baltimore, Maryland, United States
Pharmacokinetic Interaction Study of Efavirenz and American Ginseng in Healthy Volunteers
- First Posted Date
- 2010-06-04
- Last Posted Date
- 2018-06-15
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 15
- Registration Number
- NCT01136928
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
American Ginseng in Treating Patients With Fatigue Caused by Cancer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-07-21
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 364
- Registration Number
- NCT00719563
- Locations
- 🇺🇸
Memorial Hospital, Carthage, Illinois, United States
🇺🇸Illinois CancerCare - Havana, Havana, Illinois, United States
🇺🇸Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath